Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Oct;20(4):763–771. doi: 10.1128/jcm.20.4.763-771.1984

Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

J M Middeldorp, J Jongsma, A ter Haar, J Schirm, T H The
PMCID: PMC271427  PMID: 6208220

Abstract

A sensitive and reproducible enzyme-linked immunosorbent assay (ELISA) is described for the detection of immunoglobulin M and antibodies with specifity for human cytomegalovirus (CMV) early (CMV-EA) and late (CMV-LA) antigens. The emphasis is on the production of high-quality CMV antigens, CMV-EA and CMV-LA separately, and conditions for their application in the ELISA. The induction of CMV-EA and -LA in infected cell extracts was studied in detail by using human sera with defined antibody specificity for CMV-EA and CMV-LA. This resulted in the development of a simple whole cell extraction procedure that provided a high yield of CMV antigens with reproducible antigen quality. The antigens were specific for the detection of anti-CMV antibodies. The influence of autoantibodies on the determination of CMV-specific antibodies was investigated. Parallel analysis of 322 human sera by indirect immunofluorescence and ELISA showed a high correlation between both assays (r = 0.9674 for CMV-EA and 0.9362 for CMV-LA). Antibody titers determined by ELISA were equal to (for CMV-EA) or slightly higher (for CMV-LA) that those determined by immunofluorescence but significantly higher (20- to 5,120-fold) than those determined by complement fixation. From 191 sera positive by ELISA (titer greater than or equal to 40) 4 (2.1%) were negative by immunofluorescence (titer less than 40), and from 61 ELISA-positive sera 12 (19.6%) were negative (titer less than 8) when tested by complement fixation. Consequently, ELISA for CMV may prove to be more reliable for the selection of CMV-seronegative blood donors than these other methods. The use of high-quality antigens allows more economic handling of large-scale serum determinations. Possibilities for further automation are discussed.

Full text

PDF
763

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen P., Andersen H. K. Immunoglobulin levels and specific viral antibodies in relation to smooth-muscle antibodies in cytomegalovirus infection. J Clin Lab Immunol. 1978 Nov;1(3):233–236. [PubMed] [Google Scholar]
  2. Blomberg J., Nilsson I., Andersson M. Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J Clin Microbiol. 1983 Jun;17(6):1081–1091. doi: 10.1128/jcm.17.6.1081-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Booth J. C., Hannington G., Bakir T. M., Stern H., Kangro H., Griffiths P. D., Heath R. B. Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol. 1982 Dec;35(12):1345–1348. doi: 10.1136/jcp.35.12.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cappel R., de Cuyper F., de Braekeleer J. Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA). Arch Virol. 1978;58(3):253–258. doi: 10.1007/BF01317608. [DOI] [PubMed] [Google Scholar]
  5. Chen T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977 Feb;104(2):255–262. doi: 10.1016/0014-4827(77)90089-1. [DOI] [PubMed] [Google Scholar]
  6. Chia W. K., Spence L. Quantitative determination of cytomegalovirus IgG antibody by enzyme-linked immunosorbent assay (ELISA). Can J Microbiol. 1979 Sep;25(9):1082–1086. doi: 10.1139/m79-165. [DOI] [PubMed] [Google Scholar]
  7. Fey H. Use of a computer to evaluate sigmoidal curves in serology by a new procedure. J Immunol Methods. 1981;47(1):109–112. doi: 10.1016/0022-1759(81)90261-1. [DOI] [PubMed] [Google Scholar]
  8. Friedman A. D., Furukawa T., Plotkin S. A. Detection of antibody to cytomegalovirus early antigen in vaccinated, normal volunteers and renal transplant candidates. J Infect Dis. 1982 Aug;146(2):255–259. doi: 10.1093/infdis/146.2.255. [DOI] [PubMed] [Google Scholar]
  9. Gerna G., Cereda P. M., Cattaneo E., Achilli G., Revello M. G. Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections. Infect Immun. 1978 Dec;22(3):833–841. doi: 10.1128/iai.22.3.833-841.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Griffiths P. D., Stagno S., Pass R. F., Smith R. J., Alford C. A., Jr Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics. 1982 May;69(5):544–549. [PubMed] [Google Scholar]
  11. Griffiths P. D., Stagno S., Pass R. F., Smith R. J., Alford C. A., Jr Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis. 1982 May;145(5):647–653. doi: 10.1093/infdis/145.2.647. [DOI] [PubMed] [Google Scholar]
  12. Horodniceanu F., Michelson S. Assessment of human cytomegalovirus antibody detection techniques. Arch Virol. 1980;64(4):287–301. doi: 10.1007/BF01320614. [DOI] [PubMed] [Google Scholar]
  13. Kallenberg C. G., van der Meulen J., Pastoor G. W., Snijder J. A., Feltkamp T. E., The T. H. Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies. Scand J Rheumatol. 1983;12(3):193–200. doi: 10.3109/03009748309098532. [DOI] [PubMed] [Google Scholar]
  14. Kenny G. E., Dunsmoor C. L. Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay. J Clin Microbiol. 1983 Apr;17(4):655–665. doi: 10.1128/jcm.17.4.655-665.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kettering J. D., Schmidt N. J., Lennette E. H. Improved glycine-extracted complement-fixing antigen for human cytomegalovirus. J Clin Microbiol. 1977 Dec;6(6):647–649. doi: 10.1128/jcm.6.6.647-649.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kramer S. M., Jewell N. P., Cremer N. E. Discriminant analysis of data in enzyme immunoassay. J Immunol Methods. 1983 May 27;60(1-2):243–255. doi: 10.1016/0022-1759(83)90352-6. [DOI] [PubMed] [Google Scholar]
  17. Krishna R. V., Meurman O. H., Ziegler T., Krech U. H. Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus. J Clin Microbiol. 1980 Jul;12(1):46–51. doi: 10.1128/jcm.12.1.46-51.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Langenhuysen M. M., The T. H., Nieweg H. O., Kapsenberg J. G. Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. Clin Exp Immunol. 1970 Mar;6(3):387–393. [PMC free article] [PubMed] [Google Scholar]
  20. Levy E., Sarov I. Determination of IgA antibodies to human cytomegalovirus by enzyme-linked immunosorbent assay (ELISA). J Med Virol. 1980;6(3):249–257. doi: 10.1002/jmv.1890060308. [DOI] [PubMed] [Google Scholar]
  21. Malvano R., Boniolo A., Dovis M., Zannino M. ELISA for antibody measurement: aspects related to data expression. J Immunol Methods. 1982;48(1):51–60. doi: 10.1016/0022-1759(82)90209-5. [DOI] [PubMed] [Google Scholar]
  22. Rasmussen L., Kelsall D., Nelson R., Carney W., Hirsch M., Winston D., Preiksaitis J., Merigan T. C. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982 Feb;145(2):191–199. doi: 10.1093/infdis/145.2.191. [DOI] [PubMed] [Google Scholar]
  23. Ritchie D. G., Nickerson J. M., Fuller G. M. Two simple programs for the analysis of data from enzyme-linked immunosorbent (ELISA) assays on a programmable desk-top calculator. Anal Biochem. 1981 Jan 15;110(2):281–290. doi: 10.1016/0003-2697(81)90193-7. [DOI] [PubMed] [Google Scholar]
  24. Sarov I., Andersen P., Andersen H. K. Enzyme linked immunosorbent assay (ELISA) for determination of IgG antibodies to human cytomegalovirus. Acta Pathol Microbiol Scand B. 1980 Feb;88(1):1–9. doi: 10.1111/j.1699-0463.1980.tb02597.x. [DOI] [PubMed] [Google Scholar]
  25. Schmitz H., Doerr H. W., Kampa D., Vogt A. Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol. 1977 Jun;5(6):629–634. doi: 10.1128/jcm.5.6.629-634.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stagno S., Reynolds D. W., Tsiantos A., Fuccillo D. A., Long W., Alford C. A. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis. 1975 Nov;132(5):568–577. doi: 10.1093/infdis/132.5.568. [DOI] [PubMed] [Google Scholar]
  27. Stinski M. F. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol. 1977 Sep;23(3):751–767. doi: 10.1128/jvi.23.3.751-767.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sundqvist V. A., Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods. 1981 Apr;2(5):301–312. doi: 10.1016/0166-0934(81)90029-x. [DOI] [PubMed] [Google Scholar]
  29. Sutherland S., Briggs J. D. The detection of antibodies to cytomegalovirus in the sera of renal transplant patients by an IgM antibody capture assay. J Med Virol. 1983;11(2):147–159. doi: 10.1002/jmv.1890110209. [DOI] [PubMed] [Google Scholar]
  30. The T. H., Andersen H. K., Spencer E. S., Klein G. Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol. 1977 Jun;28(3):502–505. [PMC free article] [PubMed] [Google Scholar]
  31. The T. H., Klein G., Langenhuysen M. M. Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol. 1974 Jan;16(1):1-7,9-12. [PMC free article] [PubMed] [Google Scholar]
  32. Torfason E. G., Diderholm H. False RIA IgM titres to herpes simplex virus and cytomegalovirus: factors causing them, and their absorption by protein A-Sepharose/IgG-protein A-Sepharose. J Med Virol. 1982;10(3):157–170. doi: 10.1002/jmv.1890100302. [DOI] [PubMed] [Google Scholar]
  33. Voller A., Bidwell D. E. Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination. Br J Exp Pathol. 1976 Apr;57(2):243–247. [PMC free article] [PubMed] [Google Scholar]
  34. WALLER M. V., VAUGHAN J. H. Use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis. Proc Soc Exp Biol Med. 1956 May;92(1):198–200. doi: 10.3181/00379727-92-22426. [DOI] [PubMed] [Google Scholar]
  35. Wahren B., Oberg B. Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirology. 1980;12(6):335–339. doi: 10.1159/000149093. [DOI] [PubMed] [Google Scholar]
  36. Yolken R. H., Leister F. J. Enzyme immunoassays for measurement of cytomegalovirus immunoglobulin M antibody. J Clin Microbiol. 1981 Oct;14(4):427–432. doi: 10.1128/jcm.14.4.427-432.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ziegelmaier R., Behrens F., Enders G. Class-specific determination of antibodies against cytomegalo (CMV) and rubella virus by ELISA. J Biol Stand. 1981 Jan;9(1):23–33. doi: 10.1016/s0092-1157(81)80062-5. [DOI] [PubMed] [Google Scholar]
  38. van Loon A. M., van der Logt J. T., van der Veen J. Enzyme-linked immunosorbent assay for measurement of antibody against cytomegalovirus and rubella virus in a single serum dilution. J Clin Pathol. 1981 Jun;34(6):665–669. doi: 10.1136/jcp.34.6.665. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES